The American Society of Plastic Surgeons (ASPS) and other recent industry reports highlight the continued growth and evolution of aesthetic medicine trends, driven by both technological advancements and shifts in consumer behavior.
According to the ASPS’s 2023 Plastic Surgery Statistics Report, non-invasive procedures remain a dominant force, with over 25.4 million minimally invasive procedures performed in 2023—a notable increase from previous years.
Jeff Russell, Executive Director of the International Association for Physicians in Aesthetic Medicine (IAPAM), remarks on the enduring relevance of the “Lipstick Effect” in aesthetic medicine.
As inflation and economic uncertainty rise, consumers continue to prioritize affordable luxuries, such as Botox® and dermal fillers, over more expensive surgical procedures.
A Forbes analysis highlighted this trend, noting increased cosmetic spending during challenging economic times as consumers turn to small, confidence-boosting indulgences like beauty treatments to maintain their sense of well-being.
Despite economic challenges, the aesthetic medicine market has shown remarkable resilience.
The global market for minimally invasive procedures is projected to grow at a compound annual growth rate (CAGR) of 10.4% through 2030, driven by increased accessibility and interest among younger patients.
Across all generations, there is a clear shift toward minimally invasive procedures, which have grown in popularity and are outpacing surgical options, especially during times of economic uncertainty.
The age 40-55 cohort, blending Gen X and Elder Millennials, has seen a significant increase in the use of non-hyaluronic acid fillers, accounting for 35 percent of these procedures.
Meanwhile, the 30-39 age group, predominantly Millennials, experienced the highest year-over-year increase in hyaluronic acid fillers, with an 8.93 percent rise. Neuromodulators like Botox® also saw continued growth, with the 40-54 cohort accounting for 48 percent of procedures, followed by the 55-69 age group at 32 percent.
These trends highlight the growing preference for minimally invasive solutions that offer effective results, quick recovery times, and lower risks.
Russell emphasizes that the surge in demand for non-invasive procedures underscores the critical need for proper training and certification for providers.
He states, “Physicians and aesthetic providers must prioritize education that combines didactic instruction, hands-on training, and CME accreditation. This ensures both safety and optimal outcomes for patients.”
IAPAM offers comprehensive programs to meet this need, including its Aesthetic Medicine Symposium (accredited for up to 33.5 AMA PRA CAT 1 CMEs) and certification courses in botulinum toxin, dermal fillers, and advanced skin rejuvenation techniques.
As the aesthetic medicine industry evolves, providers are increasingly incorporating innovative technologies like AI-driven diagnostics, personalized treatment plans, and hybrid approaches combining non-invasive and surgical procedures.
For example, practices offering subscription-based skincare memberships or combination therapies have seen increased patient retention and revenue growth.
Laser systems and microneedling devices with RF capabilities are also becoming more accessible for smaller practices through leasing options, allowing for a broader range of services without substantial upfront costs.
While the beauty industry has historically weathered economic storms, it’s not entirely recession-proof.
For instance, during the Great Recession, premium beauty brands saw a dip in sales as consumers traded down to drugstore alternatives.
However, the overall industry remained stable, supported by the enduring appeal of self-care and affordable indulgences.
Medspas, a relatively newer segment of the beauty market, have shown resilience in recent years.
Offering non-surgical treatments like Botox and fillers caters to patients looking for cost-effective alternatives to invasive cosmetic procedures.
It’s an effective model for adding much-needed profitable revenue stream to existing medical practices as well as for anyone with a dream of opening their own successful practice one day.
By embracing digital tools and adapting to clients’ concerns and needs, they achieved remarkable growth that continues to drive the industry forward.
The aesthetic medicine industry continues to thrive, buoyed by a combination of consumer demand, innovation, and economic resilience.
With non-invasive treatments leading the charge, physicians and providers who invest in education, advanced technologies, and patient-centric care are well-positioned to capitalize on these trends.
As Russell notes, “The future of aesthetic medicine lies in offering patients safe, effective, and affordable options that enhance their confidence and quality of life.”
For more information about IAPAM’s training programs and resources, visit www.IAPAM.com.
The International Association for Physicians in Aesthetic Medicine (IAPAM) is a pioneering professional organization founded in 2006 to support healthcare providers entering the aesthetic medicine field.
With more than 10,000 providers trained, IAPAM offers comprehensive training that goes beyond simple procedure instruction.
Its proprietary Successful Aesthetic Practice System™ provides healthcare professionals with both clinical and business training, helping them add profitable, cash-based aesthetic procedures to their practices.
IAPAM distinguishes itself by offering AMA PRA Category 1 CME-accredited training programs that cover core competencies including Botox® training, light-based therapies, cosmetic injectables, skin rejuvenation, and medical weight management.
More than just a training organization, IAPAM serves as a professional development platform that helps physicians transform their practices, offering hands-on training, ongoing resources, and support to help healthcare providers grow their businesses and achieve greater professional and financial freedom.
What Providers Need to Know Now: May 2025 GLP-1 Updates GLP-1 medications continue to make headlines—and for good reason. These powerful agents are proving useful
New to injecting Botox®? This guide walks you through the most common mistakes—and how to avoid them—so you can deliver safe, natural-looking results your patients will love.
Letybo® received FDA approval on February 29, 2024, for the temporary improvement of moderate to severe glabellar lines in adult patients. With its high purity, precise diffusion pattern, and impressive clinical results, Letybo® offers medical providers a valuable new option in aesthetic medicine.
Attend the most comprehensive accredited AMA PRA CAT 1 CME Botox® training weekend, learn how to create a profitable practice with the top 5 most lucrative non-invasive treatments, get hands-on Botox® training in a multi-million dollar aesthetics practice and get trained in GLP-1 agonists and other medically-supervised weight loss treatments.
Scottsdale, Arizona
Save $3,605 when you become an IAPAM member and register to attend all 4-days!
Talk with a program advisor to discuss your hands-on or online training options for Botox®, Aesthetic Medicine and Medical Weight Management (GLP-1 inhibitors, semaglutide, tirzepatide and more).
The IAPAM has been helping physicians, nurse practitioners and physician assistants make more & work less with AMA PRA CAT 1 CME certification & training in Botox®, Aesthetic Medicine and Medical Weight Management since 2006.
Choose from online or hands-on training today!
Get side-by-side comparisons of the top Botox® training programs delivered to your inbox!
Get side-by-side comparisons of the top Botox® training programs delivered to your inbox!
